RANBAXY GETS FDA NOD FOR SCHIZOPHRENIA DRUG

Search News

The country's largest drugmaker, Ranbaxy Laboratories, received the US food and drug administration (FDA) nod to sell generic version of Risperdal used in the treatment of schizophrenia in the US. As per the information on the regulator's website, the company has got a go ahead from FDA to market and manufacture Risperidone in multiple strengths of 0.25 mg to 4 mg. The drug Risperidone is used to is used to treat the symptoms of schizophrenia. It is also to treat behaviour problems such as aggression and self-injury and sudden mood changes in teenagers and children with autism.

Find Lawyer / Law Firm

Gambling in India

The Public Gambling Act, 1867 also known as the "Gambling Act" is the primary law which governs gambling in India. However, the state legislatures, under the Constitution of India, are currentl More

Legal Consultation - Consult over phone, chat or send questions

Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion  More